Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1666 USD | -1.70% | -9.75% | +19.00% |
20/05 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
15/02 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ELITE PHARMACEUTICALS, INC. | Generic Pharmaceuticals | -1.70% | -9.75% | +19.00% | +380.12% | +103.17% | 18Cr | - | - | - |
- Stock Market
- Equities
- ELTP Stock
- Charts Elite Pharmaceuticals, Inc.
- Relative Strength Chart